Additionally, Lenvatinib-treated tumors presented reduced vascular density, as indicated by Ki-67 staining, indicating pronounced suppression of tumor proliferation in the AKR1B1-silenced group (Supplementary Fig. 30b–d). The gene discussed is AKR1B1; the disease is neoplasm.